Short Interest in Straumann Holding AG (OTCMKTS:SAUHY) Drops By 87.0%

Straumann Holding AG (OTCMKTS:SAUHY) was the target of a significant decrease in short interest in the month of January. As of January 30th, there was short interest totaling 7,573 shares, a decrease of 87.0% from the January 15th total of 58,271 shares. Based on an average daily trading volume, of 144,538 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily trading volume, of 144,538 shares, the days-to-cover ratio is currently 0.1 days.

Straumann Stock Up 1.3%

Shares of SAUHY traded up $0.17 during trading hours on Tuesday, reaching $13.04. 103,436 shares of the company traded hands, compared to its average volume of 110,920. The stock’s fifty day moving average is $12.04 and its 200 day moving average is $11.84. Straumann has a 1-year low of $10.30 and a 1-year high of $15.00.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. UBS Group upgraded shares of Straumann from a “sell” rating to a “neutral” rating in a report on Tuesday, November 4th. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research note on Monday, December 15th. The Goldman Sachs Group lowered shares of Straumann from a “strong-buy” rating to a “neutral” rating in a research note on Monday, October 13th. Citigroup reiterated a “sell” rating on shares of Straumann in a report on Wednesday, January 14th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Straumann from a “hold” rating to a “buy” rating in a research note on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Straumann has an average rating of “Hold”.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.